VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CRON
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CRONCronos Group Inc.
$3.61$1.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRONBalance Sheet

Cronos Group Inc. (CRON) Balance Sheet

13Y historyFree accessUpdated daily

Cronos maintains a fortress balance sheet with $467M cash and a 0.00 debt-to-equity ratio, though cash declined from $824.6M in Q1 2026 due to strategic deployment.

Income StatementBalance SheetCash FlowRatios

CRON Balance Sheet

Annual statement

CRON Balance Sheet

Cronos Group Inc. (CRON) balance sheet — 13-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets859.31M944.09M936.11M933.31M960.16M1.08B1.37B1.18B50.49M21.24M6.02M882.82K1.36M37.29K
Cash & Short-Term Investments741.17M831.79M858.8M861.53M877.72M1B1.29B1.13B32.66M7.32M2.58M812.39K685.29K7.29K
Cash Only411.19M791.79M858.8M669.29M764.64M886.97M1.08B901.04M23.96M7.32M2.58M812.39K685.29K7.29K
Short-Term Investments329.98M40M0192.24M113.08M117.68M211.77M230.08M000000
Accounts Receivable53.51M57.2M29.77M35.88M31.29M33.29M26.04M12.42M4.17M3.63M107K0477.62K0
Days Sales Outstanding77.87139.9792.39150.11131.67188.22203.47254.1125.45320.1494.72--262.15-
Inventory54.52M46.75M33.15M30.5M37.56M32.8M44M28.57M10.08M9.65M2.76M017.23K0
Days Inventory Outstanding117.91195.12130.92147.75192.24145.74221.37335.83622.861.76K694.64-195.5-
Other Current Assets3.83M8.34M14.39M5.41M7.11M01.18M2.44M-301.02K0202.62K020K0
Total Non-Current Assets338.7M253.05M230.07M206.96M252.85M318.02M553.51M388.43M181.41M59.11M25.9M9.73M7.21M1.25M
Property, Plant & Equipment145.24M147.29M134.58M60.82M62.83M82.95M197.38M125.05M126.2M44.67M10.51M1.95M1.12M0
Fixed Asset Turnover1.74x1.01x0.87x1.43x1.38x0.78x0.24x0.14x0.10x0.09x0.04x1.75x-0.59x-
Goodwill63.98M66.48M63.45M1.06M1.03M1.1M179.52M161.1M1.32M1.43M1.33M282.48K00
Intangible Assets7.65M8.89M11.13M21.08M26.7M18.08M69.72M53.5M8.25M8.91M8.34M1.16M1.39M0
Long-Term Investments43.7M7.66M2.81M54.74M89.75M135.16M19.23M418.34K3.08M4.1M5.72M6.34M4.68M1.25M
Other Non-Current Assets113.11M20.85M15.53M69.04M72.54M80.73M87.66M48.37M42.56M00025K0
Total Assets1.2B1.2B1.17B1.14B1.21B1.4B1.93B1.57B231.89M80.34M31.92M10.61M8.57M1.29M
Asset Turnover0.21x0.12x0.10x0.08x0.07x0.05x0.02x0.01x0.05x0.05x0.01x0.32x-0.08x-0.15x
Asset Growth %6.62%2.64%2.28%-6%-13.22%-27.42%22.65%577.06%188.63%151.71%200.82%23.78%565.74%-
Total Current Liabilities67.59M48.19M49.7M41.4M68.12M54.37M206.83M250.02M33.27M6.26M5.78M1.68M607.04K382.12K
Accounts Payable15.77M11.64M16.97M12.13M11.16M11.11M19.35M26.51M1.6M6.26M586K765.29K507.98K202.12K
Days Payables Outstanding32.0648.5867.0358.7757.1449.3797.33311.6398.671.14K147.741.93K5.76K-
Short-Term Debt0000000040.84K02.98M767.46K99.06K0
Deferred Revenue (Current)00000000000000
Other Current Liabilities020.11M40K102K15K14.38M163.41M223.18M31.63M02.22M00180K
Current Ratio12.71x19.59x18.84x22.54x14.10x19.86x6.63x4.73x1.52x3.39x1.04x0.53x2.24x0.10x
Quick Ratio11.91x18.62x18.17x21.81x13.54x19.25x6.42x4.61x1.21x1.85x0.56x0.53x2.21x0.10x
Cash Conversion Cycle163.71286.51156.27239.09266.77284.58327.51278.31649.64938.48641.62--5.83K-
Total Non-Current Liabilities5.8M5.99M5.63M2.74M3.93M9.09M10.68M6.4M2.93M5.39M1.08M500.83K607.04K202.12K
Long-Term Debt0000000004.27M0360.31K00
Capital Lease Obligations4.36M1.17M993K1.56M2.55M7.09M8.49M5.02M000000
Deferred Tax Liabilities17.9M4.09M3.56M181K081K001.36M1.13M1.08M140.52K00
Other Non-Current Liabilities0733K1.07M1M1.38M1.91M2.19M1.38M1.57M000315.28K0
Total Liabilities73.4M54.18M55.33M44.14M72.05M63.46M217.51M256.42M34.92M11.66M6.86M2.18M607.04K382.12K
Total Debt1.21M1.51M2.02M2.55M3.88M9.81M9.81M5.34M159.29K4.27M2.98M1.13M99.06K0
Net Debt-409.98M-790.28M-856.79M-666.74M-760.77M-877.17M-1.07B-895.7M-8.58M-3.05M398.63K315.39K-586.23K-7.29K
Debt / Equity0.00x0.00x0.00x0.00x0.00x0.01x0.01x0.00x0.00x0.06x0.12x0.13x0.01x-
Debt / EBITDA0.04x----------1.81x--
Net Debt / EBITDA-12.34x----------0.51x--
Interest Coverage-----8030.00x-6130.63x-392.94x-4.79x-27.85x-8.06x1.37x--
Total Equity1.12B1.14B1.11B1.1B1.14B1.33B1.71B1.31B148.55M68.68M25.06M8.43M7.96M905.41K
Equity Growth %2.24%2.88%1.36%-3.93%-14.49%-21.89%30.03%784.3%116.28%174.12%197.13%5.88%779.66%-
Book Value per Share3.262.972.882.883.033.604.863.830.860.390.320.190.250.07
Total Shareholders' Equity1.07B1.09B1.06B1.1B1.14B1.34B1.71B1.31B148.45M87.55M25.06M8.43M7.96M905.41K
Common Stock0662.98M669.88M662.17M611.32M595.5M569.26M421.47M238.87M84.7M24.99M10.67M11.7M0
Retained Earnings506.11M447.76M457.71M416.72M490.68M659.42M1.06B854.44M-38.14M-3.78M-4.62M-3.62M-4.68M-619.48K
Treasury Stock00000000000000
Accumulated OCI-58.23M-16.84M-63.52M20.68M-797K49.87M43M20.91M-13.47M4.31M1.18M598.65K728.65K0
Minority Interest52.67M49.06M46.92M-3.45M-2.92M-2.97M-3.2M-640.65K99.85K00000

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowImproving
Top Statement Risk

Geopolitical exposure in Israel

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Cash Pile Drives Fortress Balance Sheet

Cronos's balance sheet remains fortress-like with $467M cash and zero debt as of Q2 2026, according to the latest quarterly filing, though cash declined from $824.6M in Q1 2026, suggesting increased deployment.

The sequential cash decline of $357.6M from Q1 to Q2 2026 appears largely attributable to share repurchases and strategic investments, as operating cash flow turned positive. This deployment, while reducing the cash buffer, may signal management's confidence in the business trajectory, but investors should monitor the pace of cash consumption against the backdrop of record revenue growth.

Zero Leverage Provides Strategic Optionality

Cronos maintains a 0.00 debt-to-equity ratio with total debt of just $1.3M, as reported in financial statements, positioning it uniquely among cannabis peers to weather downturns and fund growth without refinancing risk.

The negligible debt level, combined with a current ratio of 16.18, suggests the company is not reliant on external financing, a stark contrast to peers like Canopy Growth (D/E 0.40) and Tilray (D/E 0.25). This balance sheet strength may allow Cronos to pursue opportunistic M&A or invest in biosynthesis without the burden of debt service, though the lack of leverage also implies a conservative capital structure that may underutilize cheap capital.

Asset-Light Model with Rising Intangibles

PP&E declined to $142.8M in Q2 2026 from $163.6M in Q4 2024, while goodwill rose to $64.1M, per balance sheet data, reflecting a shift toward brand and IP over cultivation assets.

The reduction in PP&E suggests a deliberate move away from capital-intensive cultivation, aligning with the asset-light strategy. The increase in goodwill, from $1.0M in Q2 2024 to $64.1M, likely stems from acquisitions, raising the risk of future impairment if growth expectations are not met. However, the relatively small goodwill relative to total assets ($1.2B) limits the potential impact.

Retained Earnings Turn Positive

Retained earnings reached $492.3M in Q2 2026, up from $405.6M in Q2 2024, according to the balance sheet, indicating cumulative profitability and a strengthening equity base.

The steady increase in retained earnings, despite prior losses, suggests improving operational performance and successful cost management. The equity base of $1.1B remains robust, supported by share repurchases that reduced share count, as noted in the cash flow statement. This combination of growing retained earnings and buybacks may enhance shareholder value, though the sustainability depends on continued profitability.

Ample Liquidity Despite Cash Drawdown

Cronos's current ratio of 16.18 and cash of $467M provide a substantial buffer against operational shocks, as per the latest balance sheet, though the cash balance has declined from $858.8M in Q4 2024.

The current ratio remains exceptionally high, indicating the company can cover short-term obligations over 16 times. The cash drawdown of roughly $392M over six quarters may reflect strategic investments and buybacks, but it also reduces the 'cash-box' valuation cushion. Investors should monitor whether the cash burn rate accelerates or stabilizes as the company scales operations.

Cash Decline Masks Strategic Deployment

The $357.6M sequential drop in cash from Q1 to Q2 2026, as reported in the balance sheet, may appear alarming but likely reflects share repurchases and investments, not operational losses.

While the headline cash reduction could raise concerns, the prior cash flow analysis indicates positive operating cash flow and significant buyback activity ($16.4M in Q2 2026). This suggests the cash decline is a result of deliberate capital allocation rather than cash burn. However, the lack of detailed disclosure on the use of funds warrants further investigation to confirm the deployment is value-accretive.

CRON — Frequently Asked Questions

Quick answers to the most common questions about buying CRON stock.

What are the total assets of Cronos Group Inc. (CRON)?

As of 2025, Cronos Group Inc. (CRON) had total assets of $1.20B including $944.1M in current assets.

How much debt does Cronos Group Inc. (CRON) have?

Cronos Group Inc. (CRON) carries total debt of $1.5M, offset by $831.8M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cronos Group Inc.?

Cronos Group Inc. (CRON) has total shareholders' equity (book value) of $1.09B ($2.97 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cronos Group Inc.'s current ratio and liquidity?

Cronos Group Inc. (CRON) reported a current ratio of 19.59x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.